Novel Genes of Visceral Adiposity: Identification of Mouse and Human Mesenteric Estrogen-Dependent Adipose (MEDA)-4 Gene and Its Adipogenic Function
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Visceral adiposity represents a high risk factor for type 2 diabetes, metabolic syndrome, and cardiovascular disease as well as various cancers. While studying sex hormone imbalance-induced early obesity and late onset of insulin resistance in FSH receptor knock out female mice, we identified a novel mesenteric estrogen-dependent adipose gene (MEDA-4) selectively up-regulated in a depot-specific manner in mesenteric adipose tissue. Meda-4 cloned from both mouse and human adipose tissue codes for a 34-kDa cytosolic protein with 91% homology. Mouse Meda-4 mRNA is expressed highest in visceral adipose tissue and localizes predominantly in the adipocyte fraction. Human MEDA-4 is also more abundant in omental fat than sc depot in obese patients. In 3T3-L1 cells endogenous Meda-4 expression increases early during differentiation, and its overexpression promotes differentiation of preadipocytes into adipocytes and enhances glucose uptake. Conversely, short hairpin RNA-mediated knockdown of Meda-4 reduces both adipogenic and glucose uptake potential. In promoting adipogenesis, Meda-4 up-regulates transcription factor peroxisome proliferator-activated receptor-γ2. Meda-4 promotes lipid accumulation in adipocytes, regulating adipocyte fatty acid-binding protein 2, CD36, lipoprotein lipase, hormone-sensitive lipase, acyl-Coenzyme A oxidase-1, perilipin-1, and fatty acid synthase expression. 17β-Estradiol reduced Meda-4 expression in mesenteric adipose tissue of ovariectomized mice and in 3T3-L1 adipocytes. Thus our study identifies Meda-4 as a novel adipogenic gene, capable of promoting differentiation of preadipocytes into adipocytes, increasing lipid content and glucose uptake in adipocytes. Therefore it might play an important role in adipose tissue expansion in normal and aberrant hormonal conditions and pathophysiological states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170 · cited 2×
“In obesity, excess visceral adipose tissue accumulation in both sexes is associated with adipocyte dysfunction, manifested as abnormalities in adipokines and induction of a chronic proinflammatory state that could lead to systemic insulin resistance and metabolic syndrome (1).”
BackgroundFat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085 · cited 6×
“Tontonoz P, Spiegelman BM 2008 Fat and beyond: the diverse biology of PPAR .”
BackgroundInfluentialPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 1×
“The prevalence of these conditions in postmenopausal women suggests that increases invisceral (centralabdominal)obesity (4,5) relatedto lossofovarianfunctionmaycontribute to the higher incidence of postmenopausal cardiovascular disease.”
BackgroundRegulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449 · cited 1×
“Menopausal transition (low estrogen/androgen ratio) increases the rates of obesity and metabolic syndrome during aging in women (46).”
BackgroundImpaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
Jones, M. E. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., Proietto, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12735 · Cited by 729
Ribas, V., Nguyen, M. T. A., Henstridge, D. C., Nguyen, A.-K., Beaven, S. W., Watt, M. J., & Hevener, A. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2009 · Cited by 309 · cited 1×
“Several animal studies, including FSH receptor knockout mutants (FORKO mice) (13, 14), estrogen receptorknockout mutants (15), and the aromatase knockout mice (16) demonstrate that deficiency in estrogen and/or estrogen receptor produce weight gain, increased visceral adiposity, and impaired glucose/insulin tolerance.”
BackgroundOliver-Krasinski, J. M., Kasner, M. T., Yang, J., Crutchlow, M. F., Rustgi, A. K., Kaestner, K. H., & Stoffers, D. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37028 · Cited by 177 · cited 1×
“Thus examples to note are arachidonate 5-lipoxygenase-activating protein (ALOX5AP) (43); Klotho (44); pancreatic and duodenal homeobox 1 (45).”
BackgroundFat Distribution and Insulin Sensitivity in Postmenopausal Women: Influence of Hormone Replacement
Munoz, J., Derstine, A., & Gower, B. A. (2002) · Obesity Research · doi:10.1038/oby.2002.59 · Cited by 94 · cited 1×
“Hormonal replacement therapy is known to reduce visceral obesity in postmenopausal women (47) but has other potentially adverse effects.”
Background
Cited by
The role of estrogens in the adipose tissue milieu
Bracht, J. R., Vieira‐Potter, V. J., De Souza Santos, R., Öz, O. K., Palmer, B. F., & Clegg, D. J. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14281 · Cited by 80
Importance of estrogen receptors in adipose tissue function
Blüher, M. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.07.001 · Cited by 50
Sun, J., Wang, W., Zhang, R., Duan, H., Tian, X., Xu, C., Li, X., & Zhang, D. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02074-x · Cited by 18
Metadata
- Authors
- Zhang, H., Chen, X., & Sairam, M. R.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2012-04-17
- Volume
- 153
- Issue
- 6
- Pages
- 2665-2676
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1981394514
- Cited by
- 46
- References
- 11
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.